HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

6th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 20-22, 2025 | Orlando, Florida, USA

GAB 2024

Genetic decoupling of brain networks and epigenetic factors in diseases of agency

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2024 - Denis Larrivee
University of Navarra Medical School, Spain
Title : Genetic decoupling of brain networks and epigenetic factors in diseases of agency

Abstract:

Impaired self recognition and action execution feature prominently in schizophrenia, as well as in several other cognitive diseases. Though identified as a diseases of agency, the etiology of schizophrenia, in particular, has remained obscure. Whole genome studies have thus far failed to identify gene candidates exerting more than a marginal influence on behavioral symptoms, with affected SNPs numbering well above 12,000 and pool sizes of risk alleles potentially running into the thousands. The indiscriminate and massive number of affected alleles seen in these studies implicates a higher order, organizational and regulatory impairment, rather than one involving specific genetic factors, which affects self- recognition and the ability to execute actions. Such a substrate is likely to be embedded within the interactive properties of large cell clusters such as those comprising neural circuits or even large-scale networks of the brain, which adopt top down regulatory control over behavioral and motor actions. The process of decoupling regulation from genetic oversight to one entailing a systemic and top down supracellular organization raises questions regarding whether the decoupling process itself or the systemic organization are impaired in these diseases. Given that decoupling processes involve developmental events, a failure in epigenetic mechanisms could affect the development of top down neural control leading to excessive or incorrect regulation of plasticity, thereby affecting self recognition. Alternatively, the regulatory structure itself could be the primary impairment. Consistent with this latter possibility, impaired body representations are correlated with the inability to attribute actions to oneself. Such representations are increasingly well understood – for example, several leading proposals link the sensorial representation of the body termed the peripersonal space (PPS) to the self/agent - and could offer a model for investigating the etiology of the disease. This talk will explore current findings of developmental and plastic processes and their influence on self regulation and self identification in these diseases.

Biography:

Dr. Denis Larrivee is a visiting scholar at the Mind and Brain Institute, University of Navarra Medical School and Loyola University, Chicago. He has held professorships at the Weill Cornell University Medical College, NYC, and Purdue University, Indiana. A former fellow at Yale University's Medical School, Dr. Larrivee received the Association for Research in Vision and Ophthalmology's first place award for studies on photoreceptor degenerative and developmental mechanisms. He maintains an active interest in medical imaging technology and recently published an edited volume on current advances in magnetic resonance imaging. He is the editor of six additional texts on clinical neuroscience and neurotechnology and is an editorial board member of the Annals of Neurology and Neurological Sciences (USA) and EC Neurology (UK). Dr Larrivee is the lead author of more than one hundred papers and book chapters in such varied journals/venues as IEEE Xplore, the Journal of Neuroscience, Frontiers Human Neuroscience, and the Journal of Religion and Mental Health, including a recent article in the Journal of Responsible Innovation on the integration of ethics in medical neurotechnology design. In 2018, he was a finalist for the international Joseph Ratzinger Expanded Reason award sponsored by the Francis Vittorio University of Madrid. He is currently a member of the USA based IEEE BRAIN Task Force on value based design of medical neurotechnologies.

Watsapp